Harmful variants in cellular networks divided by different forms of cancer. Lund researcher Mauno Vihinen has received a grant from the Cancer Foundation to develop AI methods that in the long run enable improved cancer diagnosis. One of the researchers who has received a grant from the Cancer Foundation is Mauno Vihinen, professor of medical structural biology at the Department of Experimental Me

https://www.medicine.lu.se/article/improved-and-tailored-prediction-methods-cancer - 2025-08-27

Pamela Buchwald and Najia Azhar have led the study that is now being published in JAMA Surgery. Photo: Private “Relapse of the condition is more common following the new treatment method using keyhole surgery, which for one-third of patients will lead to planned bowel operations. However, far fewer patients require ostomies,” says Pamela Buchwald, associate professor at Lund University and senior

https://www.medicine.lu.se/article/keyhole-surgery-ruptured-bowels-safe-long-term-method - 2025-08-27

The glymphatic system, which helps clear waste products from the brain, was discovered about a decade ago. Nicholas Bèchet’s project shines light on how it works in Alzheimer’s disease. On June 17, he defends his PhD thesis supervised by Iben Lundgaard at MultiPark. Here, he tells about his discoveries and why we should not compromise on our sleep. Tell us about your research! The glymphatic syste

https://www.multipark.lu.se/article/glymphatic-system-phd-interview-nicholas-bechet - 2025-08-27

The Bundy Academy’s 2022 major prize amounting to SEK 3 million is awarded to Sebastian Palmqvist, Associate Professor of Clinical Memory Research at Lund University and Senior Physician at the Memory Clinic at Skåne University Hospital, for his research on improved diagnostics of Alzheimer’s disease. The Bundy Academy’s 2022 major prize amounting to SEK 3 million was awarded yesterday to Sebastia

https://www.multipark.lu.se/article/awardees-2022-bundy-academy-major-prize - 2025-08-27

Anders Björklund in the Lund University doctorate ceremony procession. Photo: Paulina Pettersson. Life is like a marathon. According to Dr. Anders Björklund, a pioneer and expert in cell replacement strategies for patients with Parkinson’s Disease, so is life in academia. Along his scientific run he has passed several milestones, the most recent being a jubilee honorary doctorate awarded by Lund U

https://www.multipark.lu.se/article/looking-long-magnificent-road-neuroscientists-life-interview-anders-bjorklund - 2025-08-27

A graphical image depicting the reprogramming of human skin cells to astrocytes. Image: Cathrine Ahlenius Researchers from Lund University interested in understanding how aging affects the brain have made a new discovery that will help make it easier to study age-related brain diseases and potential treatments in the future. The key to this? human skin cells. The human brain is often likened to th

https://www.multipark.lu.se/article/how-our-skin-cells-might-be-key-better-understanding-human-brain - 2025-08-27

Enjoy the sunny (and rainy) days! Recovery is a powerful investment for your future career! As the summer holidays approach, we would like to remind all of our scientists about the imminent start of our special interest groups (SIGs). Meetings and activities will start after the summer. So take a look at the SIG in the blue box and contact the convening person to ensure that you are not missing an

https://www.multipark.lu.se/article/summer-greetings - 2025-08-27

Photo: iStock/Paul Campbell Researchers at Lund University in Sweden have developed a new method for studying age-related brain disorders. The researchers have focused on the neurodegenerative disorder Huntington’s disease and the results have now been published in the journal Brain. Basic medical research often faces the challenge of developing disease models that correspond to specific disease m

https://www.multipark.lu.se/article/researchers-reprogram-human-skin-cells-aged-neurons-study-neurodegenerative-disorders - 2025-08-27

Marta Ramos Vega defends her thesis on the 9th of September 2022. Marta Ramos’ Ph.D project unravels how inflammation and the glymphatic system affect each other in the brain. September 9, she defends her thesis. Here, she explains how you may complement your thesis project with other missions to boost your career. Tell us about your research! The glymphatic system clears waste products away from

https://www.multipark.lu.se/article/inflammation-and-glymphatic-system-phd-interview-marta-ramos - 2025-08-27

iStock Alzheimer's Association recently released recommendations about using blood-based biomarkers to detect Alzheimer’s disease. The recommendations are based on research conducted by Oskar Hansson, one of MultiPark’s research group leaders. “Blood-based biomarkers for Alzheimer’s are already improving the design of clinical trials, and they are very likely to revolutionize the diagnosis of Alzh

https://www.multipark.lu.se/article/multipark-researcher-behind-alzheimers-association-recommendations-about-use-alzheimers-blood-tests - 2025-08-27

What is the best approach for treating Alzheimer's disease? Aducanumab is an amyloid beta-directed monoclonal antibody that targets the aggregated forms of amyloid beta found in the brains of people with Alzheimer's disease. In May, Dr. Niklas Mattsson-Carlgren and Dr. Ruben Smith entertained young MultiParkers by debating the pros and cons of using it. Last summer, Aducanumab was approved by the

https://www.multipark.lu.se/article/multipark-debate-aducanumab-yesno - 2025-08-27

Malin Parmar. Photo: Kennet Ruona. The Royal Swedish Academy of Sciences has elected two new members of the Academy’s class for medical sciences. One of them is Malin Parmar, Professor of Cellular Neuroscience at Lund University. Together with her research group, Malin Parmar has conducted several groundbreaking studies on stem cells that have led to the development of new treatments for patients

https://www.multipark.lu.se/article/malin-parmar-elected-royal-swedish-academy-sciences - 2025-08-27

A Galectin-3-expressing microglia (green) close to Tau (red) inside patient brains. Photo: Antonio Boza Serrano. Inflammatory responses in the brain have long been suspected of playing a role in Alzheimer’s disease, but are challenging to monitor in the living human brain. An international collaboration including researchers at MultiPark, Lund University has made it possible to detect elevated lev

https://www.multipark.lu.se/article/biomarker-reveals-inflammatory-changes-brain-alzheimers-disease - 2025-08-27

Jessica Giacomoni defends her thesis 14 October 2022. Cell replacement therapy has long been a hope for patients with Parkinson’s disease and efforts are on their way to use stem cell derived-dopaminergic neurons in clinical trials. On 14 October, Jessica Giacomoni defends her thesis. Her project about the direct conversion of human glial cells into therapeutic neurons directly within the brain ha

https://www.multipark.lu.se/article/turning-glia-neurons-inside-brain-phd-interview-jessica-giacomoni - 2025-08-27

Photo: Mostphotos. Numerous studies have suggested that eating a healthy diet may reduce a person’s risk of dementia. A new study from one of MultiPark's research groups, published in Neurology, sheds new light on the impact of having a Mediterranean diet. The Mediterranean diet includes a high intake of vegetables, legumes, fruits, fish and healthy fats such as olive oil, and a low intake of dair

https://www.multipark.lu.se/article/does-mediterranean-diet-really-decrease-your-risk-dementia - 2025-08-27

Dopamine-producing neurons that researchers from Lund University have grown in the laboratory from human embryonic stem cells (Photo: Agneta Kirby) An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Au

https://www.multipark.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2025-08-27

Matilde Negrini defends her thesis 4 November 2022. Matilde Negrini’s thesis project has been to develop and characterize a rat model of Parkinson’s disease. November 4, she defends her thesis. Here, she talks about her project and most proud moments during her Ph.D. journey. Tell us about your research! My project has been to develop and characterize a rat model of Parkinson’s disease based on th

https://www.multipark.lu.se/article/modelling-parkinsons-disease-phd-interview-matilde-negrini - 2025-08-27

Oskar Hansson, research-leader at MultiPark, recently met with Bill Gates to discuss biomarkers for Alzheimer's disease. MultiPark’s scientists conduct world-leading research in biomarkers for Alzheimer’s disease, led by Professor Oskar Hansson at the memory clinic at Skåne University Hospital. He recently met with Bill Gates to discuss the future possibilities in this field. You met with Bill Gat

https://www.multipark.lu.se/article/multipark-researcher-bill-gates-brussels - 2025-08-27

In a large international research study with 1,300 participants from, among other places, Sweden, the USA, the Netherlands and Australia, PET cameras could detect the presence of the proteins tau and amyloid in the participants' brains. iStock/baranozedem A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any s

https://www.multipark.lu.se/article/alzheimers-disease-can-be-diagnosed-symptoms-emerge - 2025-08-27

Inducible viral vectors can be used to investigate the effect of human alpha synucelin on dopamine release and reuptake inside the rodent brain. Photo: Andreas Heuer's group. MultiPark’s backbone for research interactions is about to be reorganized. The 13 new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development

https://www.multipark.lu.se/article/brain-circuit-analysis-special-interest-group - 2025-08-27